These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8511798)

  • 1. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
    Hoorn CM; Wagner JG; Roth RA
    Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cytotoxicity of monocrotaline and its metabolites in cultured pulmonary artery endothelial cells.
    Taylor DW; Wilson DW; Lamé MW; Dunston SD; Jones AD; Segall HJ
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):196-204. PubMed ID: 9073608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
    Schultze AE; Gunaga KP; Wagner JG; Hoorn CM; Moorehead WR; Roth RA
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):301-10. PubMed ID: 8209383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The response of pulmonary vascular endothelial cells to monocrotaline pyrrole: cell proliferation and DNA synthesis in vitro and in vivo.
    Lappin PB; Ross KL; King LE; Fraker PJ; Roth RA
    Toxicol Appl Pharmacol; 1998 May; 150(1):37-48. PubMed ID: 9630451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of response of bovine and porcine pulmonary arterial endothelial cells to monocrotaline pyrrole.
    Reindel JF; Hoorn CM; Wagner JG; Roth RA
    Am J Physiol; 1991 Dec; 261(6 Pt 1):L406-14. PubMed ID: 1767861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
    Reindel JF; Roth RA
    Am J Pathol; 1991 Mar; 138(3):707-19. PubMed ID: 2000943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.
    Thomas HC; Lamé MW; Dunston SK; Segall HJ; Wilson DW
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):236-44. PubMed ID: 9707500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocrotaline pyrrole interacts with actin and increases thrombin-mediated permeability in pulmonary artery endothelial cells.
    Wilson DW; Lamé MW; Dunston SK; Taylor DW; Segall HJ
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):138-44. PubMed ID: 9772209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle alterations associated with covalent binding of monocrotaline pyrrole to pulmonary artery endothelial cell DNA.
    Thomas HC; Lamé MW; Wilson DW; Segall HJ
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):319-29. PubMed ID: 8917705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA; Reindel JF
    Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
    Schultze AE; Roth RA
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excess l-arginine restores endothelium-dependent relaxation impaired by monocrotaline pyrrole.
    Cheng W; Oike M; Hirakawa M; Ohnaka K; Koyama T; Ito Y
    Toxicol Appl Pharmacol; 2005 Sep; 207(3):187-94. PubMed ID: 16129112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
    Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocrotaline pyrrole-induced changes in angiotensin-converting enzyme activity of cultured pulmonary artery endothelial cells.
    Hoorn CM; Roth RA
    Br J Pharmacol; 1993 Oct; 110(2):597-602. PubMed ID: 8242234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic pulmonary hypertension--the monocrotaline model and involvement of the hemostatic system.
    Schultze AE; Roth RA
    J Toxicol Environ Health B Crit Rev; 1998; 1(4):271-346. PubMed ID: 9776954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium.
    Wagner JG; Petry TW; Roth RA
    Am J Physiol; 1993 May; 264(5 Pt 1):L517-22. PubMed ID: 8498528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular fibronectin and von Willebrand factor concentrations in plasma of rats treated with monocrotaline pyrrole.
    Schultze AE; Emeis JJ; Roth RA
    Biochem Pharmacol; 1996 Jan; 51(2):187-91. PubMed ID: 8615888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
    Bruner LH; Johnson K; Carpenter LJ; Roth RA
    J Toxicol Environ Health; 1987; 21(1-2):205-17. PubMed ID: 3573071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage cell checkpoint activities are altered in monocrotaline pyrrole-induced cell cycle arrest in human pulmonary artery endothelial cells.
    Wilson DW; Lamé MW; Dunston SK; Segall HJ
    Toxicol Appl Pharmacol; 2000 Jul; 166(2):69-80. PubMed ID: 10896848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.